InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Knight Peter S. Director active across 1 company, notably bioAffinity Technologies, Inc.. In total, 5 reports have been logged. Breakdown: 1 buy · 0 sell. History available since 1 January 2023. The latest transaction was filed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
KNIGHT PETER S is a Director of bioAffinity Technologies, Inc. (XNAS). He has 5 filings in total, and in the sample of recent filings covering the period from 2022-12-05 to 2024-07-02, the reported total buy amount is EUR 0 and the reported total sell amount is EUR 0, with the modal transaction nature listed as Attribution.